Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA May Drop Generic Liability Shield, Allow ANDA Manufacturers To Change Labels

This article was originally published in The Pink Sheet Daily

Executive Summary

Solicitor General notes that FDA is considering changing its regulations in an amicus brief in Mutual Pharmaceutical v. Bartlett; government says design defect claims against generic manufacturers are preempted by federal law in the case at hand but may be brought in other situations.

You may also be interested in...



FDA Proposes Unilateral Generic Drug Label Changes, Signaling End To Liability Shield

FDA proposed rule would allow ANDA holders to unilaterally make label changes prior to FDA’s approval; NDA and other ANDA holders would have 30 days to revise their labels once FDA approves the change.

FDA Labeling Change Rule Is Most Prominent Item On Agency’s To-Do List

HHS’s semi-annual inventory of rulemaking actions under development includes six prescription drug-related rules.

Generic Liability Battle Shifts With FDA’s Labeling Rule Even As Some Court Issues Remain Unresolved

Teva attorney says forthcoming proposed rule to allow ANDA holders to change their labels raises host of questions; generic manufacturers have lost some cases alleging failure to update their label, which may lead to another Supreme Court review.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS074823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel